Janus kinase 2 (JAK2) is a protein that contributes to drug-resistant cancer and its inhibition can increase cytotoxicity of chemotherapy in MDR cells [13,14,15,16] and increase the efficacy of anticancer drugs [17,18]. Here, JAK2 is linked to cancer.